Benefit of Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function.

被引：0
|
作者：
Lee, J. [1 ,2 ]
Kim, D. [1 ]
Lee, J. [1 ,2 ]
Kim, S. [1 ,3 ]
Lee, H. [4 ]
Song, S. [5 ]
Lee, J. [1 ,2 ]
Ju, M. [1 ]
Choi, G. [1 ]
Joo, D. [1 ]
Choi, J. [1 ]
Kim, S. [1 ,3 ]
Jung, Y. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea
[2] CHA Bundang, Dept Surg, Med Ctr, Seongnam, South Korea
[3] Yonsei Univ, Dept Surg, Wonju Coll Med, Wonju, South Korea
[4] Ilsan Hosp, Dept Surg, Ilsan, South Korea
[5] Ehwa Wonmen Hosp, Dept Surg, Seoul, South Korea
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D243
引用
收藏
页码：970 / 970
页数：1
相关论文
共 50 条
  • [1] Benefit of anti-hepatitis B immunoglobulin( HBIG) monotherapy compared to HBIG combined with entecavir in long term renal function
    Choi, M.
    Lee, J. G.
    Jung, Y. B.
    Kim, S., I
    Ju, M. K.
    Lee, J.
    Kim, H.
    TRANSPLANTATION, 2018, 102 : 314 - 314
  • [2] Benefit of Anti-hepatitis B Immunoglobulin (HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function
    Lee, J. G.
    Kim, D. G.
    Lee, J. J.
    Kim, S. H.
    Song, S. H.
    Lee, J. Y.
    Kwon, S. -K.
    Kim, M. S.
    Ju, M. K.
    Choi, G. H.
    Choi, J. S.
    Kim, S. I.
    Joo, D. J.
    TRANSPLANTATION, 2017, 101 (05) : 46 - 46
  • [3] Benefit of Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function
    Lee, J.
    Lee, J.
    Lee, J.
    Song, S.
    Lee, J.
    Kwon, S. -K.
    Kim, M.
    Choi, G.
    Kim, S.
    Joo, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 774 - 774
  • [4] Benefit of Anti-hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function
    Lee, Jae Geun
    Kim, Deok Gie
    Lee, Jung Jun
    Kim, Sung Hoon
    Song, Seung Hwan
    Lee, Jee Youn
    Kim, Myoung Soo
    Ju, Man Ki
    Choi, Gi Hong
    Choi, Jin Sub
    Kim, Soon Il
    Joo, Dong Jin
    TRANSPLANTATION, 2018, 102 : S127 - S127
  • [5] Renal Function Difference Between Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy and HBIG Combined with Entecavir
    Lee, Jae Geun
    Lee, Juhan
    Lee, Jung Jun
    Song, Seung Hwan
    Lee, Jee Youn
    Kim, Su-Kyung
    Ju, Man Ki
    Kim, Myoung Soo
    Choi, Gi Hong
    Choi, Jin Sub
    Kim, Soon Il
    Joo, Dong Jin
    TRANSPLANTATION, 2016, 100 : S136 - S137
  • [6] Renal Function Difference Between Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy and HBIG Combined With Entecavir
    Lee, Jae Geun
    Lee, Juhan
    Lee, Jung Jun
    Kim, Myoung Soo
    Ju, Man Ki
    Choi, Gi Hong
    Choi, Jin Sub
    Kim, Soon Il
    Joo, Dong Jin
    TRANSPLANTATION, 2015, 99 : 210 - 210
  • [7] RENAL FUNCTION DIFFERENCE BETWEEN ANTI-HEPATITIS B IMMUNOGLOBULIN (HBIG) MONOTHERAPY AND HBIG COMBINED WITH ENTECAVIR
    Lee, Jae Geun
    Ju, Man Ki
    Choi, Sub Jin
    Kim, Soon Il
    Kim, Myoung Soo
    Joo, Dong Jin
    Lee, Juhan
    Song, Seung Hwan
    TRANSPLANT INTERNATIONAL, 2015, 28 : 707 - 707
  • [8] Renal Function Difference Between Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy and HBIG Combined With Entecavir in Liver Recipients
    Lee, J.
    Lee, J.
    Lee, J.
    Kim, M.
    Ju, M.
    Choi, G.
    Choi, J.
    Kim, S.
    Joo, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [9] Combined short-term hepatitis B immunoglobulin (HBIG) and long-term lamivudine (LAM) versus HBIG monotherapy as hepatitis B virus (HBV) prophylaxis in liver transplant recipients
    Terrault, NA
    Wright, TL
    Roberts, JP
    Ascher, NL
    HEPATOLOGY, 1998, 28 (04) : 389A - 389A
  • [10] Hepatitis B immunoglobulin (HBIG) combined with long-term entecavir prophylaxis for hepatitis B virus infection in allogeneic hematopoietic stem cell transplantation with hepatitis B surface antigen-positive donors
    Shen, Yaoyao
    Qi, Jiaqian
    Wang, Yi
    Chen, Jia
    Fan, Yi
    Wang, Ying
    Wu, Depei
    Xu, Yang
    LEUKEMIA & LYMPHOMA, 2021, 62 (09) : 2284 - 2287
12345